Quanterix
The researchers found that the blood-based marker, a key product for vendor Quanterix, could aid in the diagnosis and management of several diseases.
Quanterix Q1 Revenues up 73 Percent
The company posted Q1 revenues of $27.2 million, up from $15.7 million in Q1 2020 and above the consensus Wall Street estimate of $21.4 million.
Quanterix Q4 Revenues Up 64 Percent
The company posted Q4 revenues of $26.1 million, up from $15.9 million in Q4 2019, and beat the consensus Wall Street estimate of $23.4 million.
In Brief This Week: Roche, Quanterix, Ortho Clinical Diagnostics, Veracyte, and More
News items for the in vitro diagnostics industry for the week of Feb. 8, 2021.
Quanterix Prices $250M Public Stock Offering
The company said it has priced a public offering of 3,571,428 shares of its common stock at $70.00 per share.
Dec 28, 2020
Quanterix Gets FDA EUA for SARS-CoV-2 Antibody Test
Aug 7, 2020
Quanterix Prices $85M Public Stock Offering
May 6, 2020
Quanterix Q1 Revenues Up 27 Percent
Mar 9, 2020
Quanterix Q4 Revenues Up 46 Percent
Feb 27, 2020
Nov 12, 2019
Nov 6, 2019